Medophenicol

Chloramphenicol, the active ingredient in Medophenicol, is an amphenicol presented as an oral tablet for systemic use. It is employed to treat serious bacterial infections such as typhoid fever, meningitis, rickettsial diseases, and anaerobic infections in adult patients. It is indicated for use when alternative agents are unsuitable or resistance is a concern.

GNH USA supplies Medophenicol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable sourcing for regulated markets.

Chloramphenicol is an antibacterial agent used for systemic infections caused by susceptible organisms.

- Typhoid fever: Reduces bacterial load and helps resolve systemic infection. - Meningitis: Achieves cerebrospinal fluid penetration to eradicate the causative bacteria. - Rickettsial infections: Controls intracellular organisms responsible for diseases such as typhus. - Anaerobic infections: Suppresses growth of obligate anaerobes in deep tissue or intra‑abdominal sites.

Adverse reactions may range from mild to life‑threatening and should be monitored during therapy.

Common Side Effects: - Nausea: Mild to moderate gastrointestinal upset. - Diarrhea: Loose stools that may accompany infection. - Rash: Skin erythema or pruritus. - Headache: Transient cephalic discomfort.

Serious or Rare Side Effects: - Aplastic anemia: Irreversible bone‑marrow failure requiring immediate discontinuation. - Gray syndrome: Metabolic acidosis with cardiovascular collapse, primarily in neonates. - Leukopenia or thrombocytopenia: Significant reductions in white‑blood cells or platelets. - Severe hypersensitivity: Anaphylactic reactions with respiratory compromise. - Hepatotoxicity: Elevated liver enzymes indicating liver injury.

Chloramphenicol requires careful monitoring due to its potential for serious toxicity.

- Renal impairment: Adjust monitoring as the drug is eliminated renally. - Hepatic dysfunction: Use with caution because metabolism occurs in the liver. - Blood dyscrasias: Perform regular complete blood‑count assessments. - Pregnancy: Avoid unless the therapeutic benefit outweighs potential risk (category unknown). - Drug interactions: Review concomitant medications for additive marrow toxicity. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture and light.

Chloramphenicol can alter the effects of several co‑administered medicines.

Major Interactions (Avoid): - Linezolid: Increased risk of additive bone‑marrow suppression. - Warfarin: Potential enhancement of anticoagulant effect leading to bleeding. - Aminoglycosides: Heightened risk of nephrotoxicity when combined.

Moderate Interactions (Monitor Closely): - Phenobarbital: Induces hepatic enzymes, reducing chloramphenicol plasma levels. - Oral contraceptives: May diminish contraceptive efficacy. - Alcohol: Can exacerbate hepatic injury risk.